John M. Centanni
Consejero General en COYA THERAPEUTICS, INC. .
Perfil
John M.
Centanni is Manager of Regulatory Affairs and Quality Assurance and Senior Scientist of Stratatech Corp.
He joined Stratatech in 2001.
He was a Researcher at the NCI- Frederick Cancer Research Center.
Mr. Centanni received an MS degree in Biomedical Sciences.
Cargos activos de John M. Centanni
| Empresas | Cargo | Inicio |
|---|---|---|
| COYA THERAPEUTICS, INC. | Consejero General | 01/03/2022 |
Antiguos cargos conocidos de John M. Centanni.
| Empresas | Cargo | Fin |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Consejero General | - |
Stratatech Corp.
 Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Consejero General | - |
Formación de John M. Centanni.
| Hood College | Graduate Degree |
| University of Wisconsin Oshkosh | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COYA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Stratatech Corp.
Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Commercial Services |
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John M. Centanni